ClinicalTrials.Veeva

Menu

The Effect of the Severity of COVID-19 Disease on the Incidence of Acute Renal Failure in ICU

A

Ankara City Hospital

Status

Completed

Conditions

COVID19
Acute Renal Failure

Treatments

Other: BRESCİA-COVİD Respiratory Severity Scale

Study type

Observational

Funder types

Other

Identifiers

NCT04799600
E1-20-1443

Details and patient eligibility

About

Aim of the study is to determinate the frequency of acute renal failure in COVID-19 patients, its relationship with the severity of COVID-19 disease in ICU, and the ability to take precautions against these factors.

Enrollment

158 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Patients hospitalized in the intensive care unit diagnosed with COVID-19 will include in the study.

Exclusion criteria

there is no exclusion criteria

Trial design

158 participants in 1 patient group

Acute Renal Failure in ICU
Description:
COVID-19 Patients with Acute Renal Failure in ICU
Treatment:
Other: BRESCİA-COVİD Respiratory Severity Scale

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems